The World Alzheimer Report 2021, to be published in September 2021, will focus on the crucial topic of diagnosis.
This is the fourth From Plan to Impact report. It provides a crucial update on the World Health Organization (WHO)'s Global action plan on the public health response to dementia 2017-2025.
This is the statement submitted to the 74th World Health Assembly from ADI on COVID-19, dementia and future preparedness.
This webinar focuses on the success and lessons of the South Korean example in making dementia a public health priority, with innovative thinking and technology paving the way.
This webinar focuses on the global development and distribution of COVID-19 vaccines, including issues around equitable distribution and disinformation, as well as stories of success.
The February 2021 issue of our Global Perspective newsletter.
This webinar focuses on the clinical trial data for Biogen’s investigational drug aducanumab. If approved, aducanumab would be the first disease-modifying treatment for Alzheimer’s disease.
There are over 50 million people with dementia worldwide as of 2020. An increasing proportion live in low and middle income countries. These estimates are based on the best currently available evidence as explained here.